Literature DB >> 20215560

PAR1 and PAR2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiology.

Kelly L McCoy1, Stephen F Traynelis, John R Hepler.   

Abstract

The protease-activated receptors (PAR1 and PAR2) are unusual G protein-coupled receptors that are activated by distinct serine proteases and are coexpressed in many different cell types. Limited recent evidence suggests these closely related receptors regulate different physiological outputs in the same cell, although little is known about the comparative signaling pathways used by these receptors. Here we report that PAR1 and PAR2 couple to overlapping and distinct sets of G proteins to regulate receptor-specific signaling pathways involved in cell migration. In functionally PAR-null COS-7 cells, ectopically expressed PAR1 and PAR2 both form stable complexes with G alpha(q), G alpha(11), G alpha(14), G alpha(12), and G alpha(13). It is surprising that PAR1 but not PAR2 coupled to G alpha(o), G alpha(i1), and G alpha(i2). Consistent with these observations, PAR1 and PAR2 stimulation of inositol phosphate production and RhoA activation was blocked by specific inhibitors of G(q/11) and G(12/13) signaling, respectively. Both receptors stimulated extracellular signal-regulated kinase (ERK) 1/2 phosphorylation, but only PAR1 inhibited adenylyl cyclase activity, and pertussis toxin blocked PAR1 effects on both adenylyl cyclase and ERK1/2 signaling. Neu7 astrocytes express native PAR1 and PAR2 receptors that activate inositol phosphate, RhoA, and ERK1/2 signaling. However, only PAR1 inhibited adenylyl cyclase activity. PAR1 and PAR2 also stimulate Neu7 cell migration. PAR1 effects on ERK1/2 phosphorylation and cell migration were blocked both by pertussis toxin and by the mitogen-activated protein kinase kinase/ERK inhibitor [1,4-diamino-2,3-dicyano-1,4-bis(methylthio)butadiene (U0126)], whereas PAR2 effects were only blocked by U0126. These studies demonstrate that PAR1 and PAR2 physically and functionally link to overlapping and distinct profiles of G proteins to differentially regulate downstream signaling pathways and cell physiology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20215560      PMCID: PMC2879918          DOI: 10.1124/mol.109.062018

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  47 in total

Review 1.  Proteinase-activated receptors.

Authors:  S R Macfarlane; M J Seatter; T Kanke; G D Hunter; R Plevin
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

2.  Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide.

Authors:  B D Blackhart; L Ruslim-Litrus; C C Lu; V L Alves; W Teng; R M Scarborough; E E Reynolds; D Oksenberg
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

3.  Antagonistic regulation of neurite morphology through Gq/G11 and G12/G13.

Authors:  Alexander Nürnberg; Anja U Braüer; Nina Wettschureck; Stefan Offermanns
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

4.  Thrombin receptors activate G(o) proteins in endothelial cells to regulate intracellular calcium and cell shape changes.

Authors:  Jurgen F Vanhauwe; Tarita O Thomas; Richard D Minshall; Chinnaswamy Tiruppathi; Anli Li; Annette Gilchrist; Eun-ja Yoon; Asrar B Malik; Heidi E Hamm
Journal:  J Biol Chem       Date:  2002-05-30       Impact factor: 5.157

5.  Thrombomodulin as a new marker of lesion-induced astrogliosis: involvement of thrombin through the G-protein-coupled protease-activated receptor-1.

Authors:  A Pindon; M Berry; D Hantaï
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

6.  PAR1, but not PAR4, activates human platelets through a Gi/o/phosphoinositide-3 kinase signaling axis.

Authors:  Bryan Voss; Joseph N McLaughlin; Michael Holinstat; Roy Zent; Heidi E Hamm
Journal:  Mol Pharmacol       Date:  2007-02-15       Impact factor: 4.436

7.  Agonist-biased signaling via proteinase activated receptor-2: differential activation of calcium and mitogen-activated protein kinase pathways.

Authors:  Rithwik Ramachandran; Koichiro Mihara; Maneesh Mathur; Moulay Driss Rochdi; Michel Bouvier; Kathryn Defea; Morley D Hollenberg
Journal:  Mol Pharmacol       Date:  2009-07-15       Impact factor: 4.436

8.  Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines.

Authors:  Alexander G Vandell; Nadya Larson; Gurunathan Laxmikanthan; Michael Panos; Sachiko I Blaber; Michael Blaber; Isobel A Scarisbrick
Journal:  J Neurochem       Date:  2008-09-06       Impact factor: 5.372

9.  Protease-activated receptor 1-dependent neuronal damage involves NMDA receptor function.

Authors:  Cecily E Hamill; Guido Mannaioni; Polina Lyuboslavsky; Aristide A Sastre; Stephen F Traynelis
Journal:  Exp Neurol       Date:  2009-02-10       Impact factor: 5.330

10.  beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2.

Authors:  K A DeFea; J Zalevsky; M S Thoma; O Déry; R D Mullins; N W Bunnett
Journal:  J Cell Biol       Date:  2000-03-20       Impact factor: 10.539

View more
  27 in total

1.  Protease-activated receptor 1 (PAR1) coupling to G(q/11) but not to G(i/o) or G(12/13) is mediated by discrete amino acids within the receptor second intracellular loop.

Authors:  Kelly L McCoy; Stefka Gyoneva; Christopher P Vellano; Alan V Smrcka; Stephen F Traynelis; John R Hepler
Journal:  Cell Signal       Date:  2012-01-28       Impact factor: 4.315

2.  Genetic targeting of protease activated receptor 2 reduces inflammatory astrogliosis and improves recovery of function after spinal cord injury.

Authors:  Maja Radulovic; Hyesook Yoon; Jianmin Wu; Karim Mustafa; Michael G Fehlings; Isobel A Scarisbrick
Journal:  Neurobiol Dis       Date:  2015-08-24       Impact factor: 5.996

Review 3.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer.

Authors:  Mohammad Jaber; Miriam Maoz; Arun Kancharla; Daniel Agranovich; Tamar Peretz; Sorina Grisaru-Granovsky; Beatrice Uziely; Rachel Bar-Shavit
Journal:  Cell Mol Life Sci       Date:  2013-11-01       Impact factor: 9.261

Review 5.  Activated protein C: biased for translation.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

6.  Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia.

Authors:  Leila M Sevigny; Karyn M Austin; Ping Zhang; Shogo Kasuda; Georgios Koukos; Sheida Sharifi; Lidija Covic; Athan Kuliopulos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-09-22       Impact factor: 8.311

7.  Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2).

Authors:  Rithwik Ramachandran; Koichiro Mihara; Hyunjae Chung; Bernard Renaux; Chang S Lau; Daniel A Muruve; Kathryn A DeFea; Michel Bouvier; Morley D Hollenberg
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

8.  PAR-2 triggers placenta-derived protease-induced altered VE-cadherin reorganization at endothelial junctions in preeclampsia.

Authors:  Y Gu; L J Groome; J S Alexander; Y Wang
Journal:  Placenta       Date:  2012-07-26       Impact factor: 3.481

9.  Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (CXC motif) receptor 4.

Authors:  Xianlong Gao; You-Hong Cheng; Garrett A Enten; Anthony J DeSantis; Vadim Gaponenko; Matthias Majetschak
Journal:  J Biol Chem       Date:  2020-08-24       Impact factor: 5.157

10.  Activation of ATP secretion via volume-regulated anion channels by sphingosine-1-phosphate in RAW macrophages.

Authors:  Philipp Burow; Manuela Klapperstück; Fritz Markwardt
Journal:  Pflugers Arch       Date:  2014-06-26       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.